Analysts See $-0.17 EPS for K2M Group Holdings, Inc. (KTWO)

October 14, 2018 - By Hazel Jackson

K2M Group Holdings, Inc. (NASDAQ:KTWO) Logo

Analysts expect K2M Group Holdings, Inc. (NASDAQ:KTWO) to report $-0.17 EPS on November, 7.They anticipate $0.03 EPS change or 15.00 % from last quarter’s $-0.2 EPS. After having $-0.25 EPS previously, K2M Group Holdings, Inc.’s analysts see -32.00 % EPS growth. The stock decreased 0.11% or $0.03 during the last trading session, reaching $27.33. About 1.98M shares traded or 99.68% up from the average. K2M Group Holdings, Inc. (NASDAQ:KTWO) has risen 17.76% since October 14, 2017 and is uptrending. It has outperformed by 2.14% the S&P500.

K2M Group Holdings, Inc. (NASDAQ:KTWO) Ratings Coverage

Among 5 analysts covering K2M Group Holdings (NASDAQ:KTWO), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. K2M Group Holdings had 6 analyst reports since May 2, 2018 according to SRatingsIntel. On Tuesday, September 4 the stock rating was downgraded by Cantor Fitzgerald to “Neutral”. Needham maintained it with “Buy” rating and $2300 target in Wednesday, May 2 report. Oppenheimer downgraded the shares of KTWO in report on Friday, August 31 to “Perform” rating. As per Monday, September 24, the company rating was downgraded by RBC Capital Markets. Cowen & Co downgraded K2M Group Holdings, Inc. (NASDAQ:KTWO) on Wednesday, September 5 to “Market Perform” rating. The firm has “Buy” rating by Cantor Fitzgerald given on Thursday, May 31.

K2M Group Holdings, Inc., a medical device company, focuses on designing, developing, and commercializing spine and minimally invasive solutions in the United States and internationally. The company has market cap of $1.19 billion. The firm provides implants, disposables, and instruments primarily to hospitals for use by spine surgeons to treat spinal pathologies, such as deformity, trauma, and tumor. It currently has negative earnings. The Company’s complex spine products include EVEREST, MESA, MESA 2, and DENALI deformity spinal systems; NILE alternative fixation systems; MESA rail deformity spinal systems; Cricket and Quicket deformity systems; CAPRI corpectomy cage systems; MESA small stature, rail small stature, and mini spinal systems; SERENGETI complex spine minimally invasive retractor systems; RAVINE complex spine lateral access systems; and SANTORINI corpectomy cage systems.

More recent K2M Group Holdings, Inc. (NASDAQ:KTWO) news were published by: which released: “The Daily Biotech Pulse: Clinical Hold Lifted Off Crispr’s Gene-Edited Therapy, Endra To Offer Shares” on October 11, 2018. Also published the news titled: “K2M Group (KTWO) Announces FDA Clearance Including Surgical Guidance that Enhances MESA Platform” on October 10, 2018.‘s news article titled: “Analysis: Positioning to Benefit within MINDBODY, CVR Energy, Superior Industries International, K2M Group, Duke …” with publication date: October 10, 2018 was also an interesting one.

K2M Group Holdings, Inc. (NASDAQ:KTWO) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: